ABT Abbott Laboratories

Price (delayed)

$109.95

Market cap

$191.71B

P/E Ratio

24.6

Dividend/share

$1.92

EPS

$4.47

Enterprise value

$198.53B

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott ...

Highlights
ABT's P/E is 59% below its 5-year quarterly average of 59.9 and 8% below its last 4 quarters average of 26.7
Abbott Laboratories's debt has decreased by 11% YoY and by 2.1% QoQ
The EPS has grown by 10% YoY but it has contracted by 7% from the previous quarter
Abbott Laboratories's net income has increased by 9% YoY but it has decreased by 8% QoQ
ABT's quick ratio is down by 8% since the previous quarter and by 2.4% year-on-year

Key stats

What are the main financial stats of ABT
Market
Shares outstanding
1.74B
Market cap
$191.71B
Enterprise value
$198.53B
Valuations
Price to earnings (P/E)
24.6
Price to book (P/B)
5.37
Price to sales (P/S)
4.28
EV/EBIT
20.16
EV/EBITDA
15.05
EV/Sales
4.41
Earnings
Revenue
$45.03B
EBIT
$9.85B
EBITDA
$13.19B
Free cash flow
$8.54B
Per share
EPS
$4.47
Free cash flow per share
$4.87
Book value per share
$20.49
Revenue per share
$25.69
TBVPS
$22.63
Balance sheet
Total assets
$72.8B
Total liabilities
$36.92B
Debt
$16.41B
Equity
$35.88B
Working capital
$11.48B
Liquidity
Debt to equity
0.46
Current ratio
1.86
Quick ratio
1.22
Net debt/EBITDA
0.52
Margins
EBITDA margin
29.3%
Gross margin
57.1%
Net margin
17.5%
Operating margin
21%
Efficiency
Return on assets
10.7%
Return on equity
21.9%
Return on invested capital
28.5%
Return on capital employed
16.6%
Return on sales
21.9%
Dividend
Dividend yield
1.75%
DPS
$1.92
Payout ratio
43%

ABT stock price

How has the Abbott Laboratories stock price performed over time
Intraday
-1.01%
1 week
-2.54%
1 month
1.27%
1 year
-8.71%
YTD
0.15%
QTD
0.15%

Financial performance

How have Abbott Laboratories's revenue and profit performed over time
Revenue
$45.03B
Gross profit
$25.72B
Operating income
$9.44B
Net income
$7.89B
Gross margin
57.1%
Net margin
17.5%
The operating income has grown by 11% YoY but it has contracted by 8% from the previous quarter
Abbott Laboratories's net income has increased by 9% YoY but it has decreased by 8% QoQ
The gross profit has increased by 7% year-on-year but it has declined by 2.7% since the previous quarter
Abbott Laboratories's net margin has decreased by 7% QoQ but it has increased by 2.3% YoY

Growth

What is Abbott Laboratories's growth rate over time

Valuation

What is Abbott Laboratories stock price valuation
P/E
24.6
P/B
5.37
P/S
4.28
EV/EBIT
20.16
EV/EBITDA
15.05
EV/Sales
4.41
ABT's P/E is 59% below its 5-year quarterly average of 59.9 and 8% below its last 4 quarters average of 26.7
The EPS has grown by 10% YoY but it has contracted by 7% from the previous quarter
ABT's price to book (P/B) is 6% lower than its last 4 quarters average of 5.7 but 5% higher than its 5-year quarterly average of 5.1
ABT's equity is up by 3.6% year-on-year but it is down by 2.3% since the previous quarter
ABT's P/S is 9% below its 5-year quarterly average of 4.7 and 7% below its last 4 quarters average of 4.6
The revenue has grown by 6% YoY

Efficiency

How efficient is Abbott Laboratories business performance
The ROIC has grown by 8% YoY but it has contracted by 7% from the previous quarter
ABT's ROE is down by 8% from the previous quarter but it is up by 2.3% YoY
Abbott Laboratories's return on assets has increased by 8% YoY but it has decreased by 7% QoQ
The ROS has contracted by 6% from the previous quarter but it has grown by 5% YoY

Dividends

What is ABT's dividend history
DPS
$1.92
Dividend yield
1.75%
Payout ratio
43%
Recent dividends

Financial health

How did Abbott Laboratories financials performed over time
The total assets is 97% more than the total liabilities
ABT's quick ratio is down by 8% since the previous quarter and by 2.4% year-on-year
The current ratio has decreased by 7% QoQ
Abbott Laboratories's debt is 54% lower than its equity
Abbott Laboratories's debt to equity has decreased by 13% YoY
Abbott Laboratories's debt has decreased by 11% YoY and by 2.1% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.